Health

Study: Weight-Loss Injections Linked to Rapid Weight Regain

Are GLP-1 drugs a valuable medical tool when combined with lifestyle changes, or just a short-term fix with rapid weight regain?

Published JAN 8

Study: Weight-Loss Injections Linked to Rapid Weight Regain

Story

Above: A box of Ozempic inside a pharmacy in Los Angeles, Calif. on Aug. 6, 2025. Image credit: Eric Thayer/Bloomberg/Getty Images

The Facts

Research published in the British Medical Journal on Wednesday analyzed 37 studies involving more than 9,000 participants and found that people using weight management medications — including weight‑loss injections — regained an average of 0.4 kg (0.9 lb) per month after stopping treatment, returning to their pre-treatment weight within approximately 1.7 years.
BMJ
The Oxford University study found that weight regain occurred almost four times faster for people who stopped weight loss medications than for those leaving behavioral weight management programs, where regain averaged about 0.1 kg per month.
University of Oxford
Healthcare Management
The review included GLP‑1 receptor agonist medications, such as semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound), though only eight of the 37 studies assessed these newer drugs, and follow-up was limited to one year after treatment stopped.
Hellorayo
News Medical
Cardiometabolic markers, including blood sugar, cholesterol, and blood pressure, improved during medication use but were projected to return to baseline within roughly 1.4 years after stopping, following the same pattern as weight regain.
RTE.ie
Daily Mail
Across the studies, participants were treated for an average of 39 weeks and followed for an average of 32 weeks after stopping medication.
University of Oxford
People
According to University College London research funded by Cancer Research UK, an estimated 1.6 million adults in the U.K. used weight loss drugs between early 2024 and early 2025. An additional 3.3 million people expressed interest in using these medications over the next year.
BBC News
SpringerLink

Sources Split

LEFT

CENTER

RIGHT

ESTAB
CRIT

CENTER

PRO
ESTAB

The Spin

Narrative A

Weight‑loss injections like Ozempic and Wegovy can produce quick results, but most users regain nearly all lost weight within a year, often faster than people following diet and exercise programs. The drugs create dependence without building lasting habits, and prolonged use can carry health risks, making lifelong reliance unrealistic and unsafe. Relying on expensive, short-term interventions while ignoring behavioral change sets millions up for failure and wastes resources on a fleeting fix.

BMJ

Guardian

Independent

Narrative B

GLP‑1 drugs like Ozempic and Wegovy can be a powerful tool for adults with obesity when combined with diet, exercise and professional support. They can produce up to 20% weight loss and reduce risks of heart attack, stroke and diabetes by around 20% over three years. Although sometimes seen as a "quick fix," these therapies offer millions a medically validated option to supplement lifestyle changes in managing a chronic condition that causes 3.7 million deaths globally each year.